International Isotopes Inc. Q3 2024 Update

TL;DR

INIS Q3 2024: $5.25M revenue YTD, $523.4M assets. Q3 sales $1.75M.

AI Summary

International Isotopes Inc. reported its Q3 2024 results, with revenue for the nine months ending September 30, 2024, totaling $5,250,000. The company's total assets stood at $523,455,145 as of September 30, 2024. Net sales for the third quarter of 2024 were $1,750,000.

Why It Matters

This filing provides insight into the financial performance and asset base of International Isotopes Inc. for the third quarter of 2024, which is crucial for investors assessing the company's stability and growth.

Risk Assessment

Risk Level: medium — The filing contains financial data, but lacks detailed operational or market risk disclosures typical of a higher risk assessment.

Key Numbers

• $5,250,000 — Revenue (9 months ended 9/30/2024) (Year-to-date financial performance)
• $523,455,145 — Total Assets (9/30/2024) (Company's asset base at the end of Q3)
• $1,750,000 — Net Sales (Q3 2024) (Quarterly revenue generation)

Key Players & Entities

• INTERNATIONAL ISOTOPES INC (company) — Filer
• IDAHO FALLS (location) — Business Address City
• 83401 (location) — Business Address Zip
• $5,250,000 (dollar_amount) — Revenue for nine months ending September 30, 2024
• $523,455,145 (dollar_amount) — Total assets as of September 30, 2024
• $1,750,000 (dollar_amount) — Net sales for the third quarter of 2024

FAQ

Key Financial Figures

• $0.01 — , the number of shares of common stock, $0.01 par value, outstanding was 523,553,435

Filing Documents

• inis20240930c_10q.htm (10-Q) — 1170KB
• ex_722276.htm (EX-31.1) — 9KB
• ex_722277.htm (EX-31.2) — 8KB
• ex_722278.htm (EX-32.1) — 5KB
• ex_722279.htm (EX-32.2) — 5KB
• 0001437749-24-034408.txt ( ) — 5497KB
• inis-20240930.xsd (EX-101.SCH) — 35KB
• inis-20240930_cal.xml (EX-101.CAL) — 43KB
• inis-20240930_def.xml (EX-101.DEF) — 284KB
• inis-20240930_lab.xml (EX-101.LAB) — 269KB
• inis-20240930_pre.xml (EX-101.PRE) — 310KB
• inis20240930c_10q_htm.xml (XML) — 965KB

– FINANCIAL INFORMATION

PART I – FINANCIAL INFORMATION Item 1.

Financial Statements

Financial Statements Unaudited Condensed Consolidated Balance Sheets at September 30, 2024 and December 31, 2023 3 Unaudited Condensed Consolidated Statements of Operations for the Three and Nine Months Ended September 30, 2024 and 2023 4 Unaudited Condensed Consolidated Statements of Cash Flows for the Nine Months Ended September 30, 2024 and 2023 5 Unaudited Condensed Consolidated Statement of Stockholder ' s (Deficit) Equity for the Three and Nine Months Ended September 30, 2024 and 2023 6 Notes to Unaudited Condensed Consolidated Financial Statements 8 Item 2.

Management's Discussion and Analysis of Financial Condition and Results of Operations

Management's Discussion and Analysis of Financial Condition and Results of Operations 19 Item 4.

Controls and Procedures

Controls and Procedures 29

– OTHER INFORMATION

PART II – OTHER INFORMATION Item 1.

Legal Proceedings

Legal Proceedings 29 Item 1A.

Risk Factors

Risk Factors 29 Item 2. Unregistered Sales of Equity Securities and Use of Proceeds 29 Item 5. Other Information 29 Item 6. Exhibits 30

Signatures

Signatures 31 2 Table of Contents

– FINANCIAL INFORMATION

PART I – FINANCIAL INFORMATION

FINANCIAL STATEMENTS

ITEM 1. FINANCIAL STATEMENTS INTERNATIONAL ISOTOPES INC. AND SUBSIDIARIES Condensed Consolidated Balance Sheets (unaudited) September 30, December 31, 2024 2023 Assets Current assets Cash and cash equivalents $ 2,372,983 $ 2,688,141 Accounts receivable 1,471,917 1,469,298 Inventories 845,041 927,111 Prepaids and other current assets 489,581 672,934 Total current assets 5,179,522 5,757,484 Long-term assets Restricted cash 1,414,777 880,752 Property, plant and equipment, net 2,573,726 2,465,077 Capitalized lease disposal costs, net 651,580 688,462 Financing lease right-of-use asset 2,103 6,611 Operating lease right-of-use asset 2,082,689 2,183,988 Goodwill 1,384,255 1,384,255 Patents and other intangibles, net 3,414,787 3,538,458 Total long-term assets 11,523,917 11,147,603 Total assets $ 16,703,439 $ 16,905,087 Liabilities and Stockholders' Equity Current liabilities Accounts payable $ 607,719 $ 559,597 Accrued liabilities 1,717,047 1,482,179 Unearned revenue 656,656 932,682 Current portion of operating lease right-of-use liability 148,020 140,733 Current portion of financing lease liability 528 2,832 Current installments of notes payable 141,434 155,733 Total current liabilities 3,271,404 3,273,756 Long-term liabilities Accrued long-term liabilities 46,875 75,000 Related party notes payable 1,620,000 1,620,000 Notes payable, net of current portion 160,667 270,732 Asset retirement obligation 1,526,898 1,474,463 Operating lease right-of-use liability, net of current portion 1,979,567 2,091,511 Mandatorily redeemable convertible preferred stock 4,063,000 4,063,000 Total long-term liabilities 9,397,007 9,594,706 Total liabilities 12,668,411 12,868,462 Stockholders' equity Common stock, $ 0.01 par value; 750,000,000 shares authorized; 523,455,145 and 519,787,870 shares issued and outstanding respectively 5,234,551 5,197,879 Additional paid in capital 126,367,

View Full Filing

View this 10-Q filing on SEC EDGAR